Search results for "respiratory tract"

showing 10 items of 1170 documents

Update on perioperative management of the child with asthma

2012

Asthma represents the leading cause of morbidity from a chronic disease among children. Dealing with this disease during the perioperative period of pediatric surgical procedures is, therefore, quite common for the anesthesiologist and other professionalities involved. Preoperative assessment has a key role in detecting children at increased risk of perioperative respiratory complications. For children without an optimal control of symptoms or with a recent respiratory tract infection elective surgery should be postponed, if possible, after the optimization of therapy. According to clinical setting, loco-regional anesthesia represents the desirable option since it allows to avoid airway ins…

medicine.medical_specialtyPathophysiology of asthmamedicine.medical_treatmentlcsh:MedicineSettore MED/41 - AnestesiologiaReviewPediatricsAsthma; Pediatric; Perioperative managementPerioperative managementMedicineElective surgeryMED/41 - ANESTESIOLOGIAIntensive care medicineAsthmapediatric asthma perioperative managementMechanical ventilationPediatricperioperative management.business.industrylcsh:RTracheal intubationlcsh:RJ1-570lcsh:PediatricsPerioperativemedicine.diseaseAsthmarespiratory tract diseasesAirway managementpediatric asthma perioperative management.Airwaybusiness
researchProduct

The paradox of the evidence about invasive fungal infections prevention

2016

Invasive fungal infections (IFIs) are characterized by high morbidity and mortality in non-neutropenic critically ill patients. Attributable mortality due to Candida spp. infections ranges from about 42 to 63 % [1, 2]. Data from large observational and retrospective studies show an association between early antifungal treatment and improved survival [3, 4]. Updated clinical practice guidelines for the management of candidiasis have been recently published [5]. In 2006, Playford et al. published a Cochrane systematic review investigating the use of antifungal agents for prevention of IFIs in non-neutropenic critically ill patients [6]. In that review, the outcome of proven IFI was defined as…

medicine.medical_specialtyPediatricsAntifungal AgentsUrinary systemMEDLINECritical Care and Intensive Care Medicinelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicinemedicineAntifungal AgentHumansInfection controlInvasive Fungal Infection030212 general & internal medicinebusiness.industryAntifungal Agents; Humans; Invasive Fungal Infections; Critical Care and Intensive Care Medicine030208 emergency & critical care medicineRetrospective cohort studyFungal EsophagitisEditorialmedicine.anatomical_structureObservational studybusinessInvasive Fungal InfectionsHumanRespiratory tractCritical Care
researchProduct

Reslizumab (RES) in asthma patients (pts) with severe eosinophilic asthma stratified by GINA asthma steps 4 and 5: Analysis of two phase 3, placebo (…

2016

Background: RES reduced exacerbation frequency and improved lung function and asthma control in pts with inadequately controlled asthma and elevated blood eosinophils (EOS) in two PBO-controlled, phase 3 trials (Castro et al. Lancet Resp Med 2015). Aims/objectives: To determine the efficacy of RES in asthma pts stratified by GINA Step 4 (G4) and Step 5 (G5) categories of asthma severity. Methods: Pooled data from two 52-week, PBO-controlled trials of RES (3mg/kg IV Q4W) in pts with inadequately controlled asthma and blood EOS ≥400/µL on inhaled corticosteroid (ICS) ± another controller; primary results have been reported. Current analysis includes pts stratified by G4 (medium/high-dose ICS …

medicine.medical_specialtyPediatricsExacerbationbusiness.industrymedicine.drug_classEosinophilic asthmaPlaceboRate ratiomedicine.diseaserespiratory tract diseases03 medical and health sciences0302 clinical medicine030228 respiratory systemReslizumabInternal medicineAsthma controlMedicineCorticosteroid030212 general & internal medicinebusinessmedicine.drugAsthma5.1 Airway Pharmacology and Treatment
researchProduct

Best practices, challenges and innovations in pediatrics in 2019

2020

AbstractThis paper runs through key progresses in epidemiology, pathomechanisms and therapy of various diseases in children that were issued in the Italian Journal of Pediatrics at the end of last year. Novel research and documents that explore areas such as allergy, critical care, endocrinology, gastroenterology, infectious diseases, neonatology, neurology, nutrition, and respiratory tract illnesses in children have been reported. These observations will help to control childhood illnesses.

medicine.medical_specialtyPediatricsRespiratory diseasesAllergyBest practiceAmbulancesRespiratory Tract DiseasesPainTurner SyndromeReviewPediatricsInfant Newborn DiseasesEndocrinologyEpidemiologymedicineEnterovirus InfectionsHypersensitivityHumansNeonatologyChildrenGrowth DisordersNutritionInfectious diseaseNoninvasive Ventilationbusiness.industryMaternal and child healthMalnutritionVaccinationInfant NewbornVirtual Realitylcsh:RJ1-570GastroenterologyTooth InjuriesOsteomyelitislcsh:PediatricsGeneral MedicineObject AttachmentSettore MED/38Jaundice ObstructiveCritical careNeurologyInfectious diseasesNeonatologybusinessSpinal Cord CompressionHand Disinfection
researchProduct

Prescription of automatic bilevel ventilation (AutoBI) in sleep-disordered breathing: analysis according to diagnosis and occurrence of comorbidities

2017

CPAP is the first-choice treatment for obstructive sleep-disordered breathing (O-SDB), while the criteria to prescribe AutoBI are undefined. Trials of AutoBI ventilation in patients (pts) treated for O-SDB from January 2015 to October 2016 (64 out of 242 titrations) were reviewed to assess: a) the clinical characteristics of these pts, b) the reason to shift from CPAP to AutoBI, c) the compliance to prescribed treatment. AutoBI was used in cases of intolerance to high therapeutic CPAP levels (n=21) or incomplete resolution of SDB on CPAP (n=43). The Table reports the differences between CPAP or AutoBI pts CPAP SDB diagnosis was: 82% OSA, 18% OSA-COPD Overlap in the CPAP group; 39% OSA, 28% …

medicine.medical_specialtyPediatricsbusiness.industryNocturnal hypoventilationSevere obesitynervous system diseasesrespiratory tract diseasesBreathingmedicineSleep disordered breathingIn patientMedical prescriptionIntensive care medicinebusinessTreatments and CPAP
researchProduct

Late-asthma onset and associated factors

2016

Although asthma is usually considered to originate in childhood, adult-onset is being increasingly reported. Aim: to assess factors associated to early- (<18 yrs) and late-onset (≥18 yrs) asthma. Methods: Data from a web-based Italian severe/uncontrolled asthma (SUA) registry (released in 2014), including 577 SUA subjects from 6 clinical and epidemiological Italian centres (Pisa1, Perugia, Ancona, Verona, Palermo, Pisa2). Results: 77.5% of SUA subjects had a late-onset asthma. Among subjects with early-onset asthma there were higher frequencies of allergic asthma (92.1 vs 76.4%), asthma familiarity (52.8 vs 42.8%), seasonal symptoms (51.3 vs 27.6%), active smoking habits (8.5 vs 4.4%) and u…

medicine.medical_specialtyPediatricsbusiness.industryOccupational riskOverweightmedicine.diseaseLower riskObesityrespiratory tract diseasesAtopyEpidemiologymedicinemedicine.symptombusinessOccupational asthmaAsthma6.1 Epidemiology
researchProduct

Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report.

2021

RATIONALE: Pityriasis rosea Gibert is an erythematous-papulosquamous dermatosis that frequently occurs in young adults. The etiopathogenesis of PR is still unknown, but is frequently associated with episodes of upper respiratory tract infections. It is likely that a new viral trigger of pityriasis rosea is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). PATIENT CONCERNS: We present the case of a female patient in whom the diagnosis of pityriasis rosea led to the investigation and diagnosis of the SARS-CoV-2 infection. The patient presented to the Department of Dermatology for a 3 week duration of an extremely pruritic erythematous-squamous lesion, initially on the trunk …

medicine.medical_specialtyPityriasis RoseaContext (language use)Lesion03 medical and health sciencescoronavirus disease 20190302 clinical medicineAdrenal Cortex HormonesmedicineHumans030212 general & internal medicineClinical Case ReportRespiratory tract infectionsbusiness.industrySARS-CoV-24900COVID-19pityriasis rosea GibertGeneral MedicineMiddle Agedmedicine.diseaseDermatologyRashTopical medicationmedicine.anatomical_structure030220 oncology & carcinogenesisPityriasis roseaEtiologyFemalemedicine.symptombusinessRespiratory tractResearch Articlesevere acute respiratory syndrome coronavirus 2Medicine
researchProduct

Community acquired pneumonia in children: Treatment of complicated cases and risk patients. Consensus statement by the Spanish Society of Paediatric …

2015

The incidence of community-acquired pneumonia complications has increased during the last decade. According to the records from several countries, empyema and necrotising pneumonia became more frequent during the last few years. The optimal therapeutic approach for such conditions is still controversial. Both pharmacological management (antimicrobials and fibrinolysis), and surgical management (pleural drainage and video-assisted thoracoscopic surgery), are the subject of continuous assessment. In this paper, the Spanish Society of Paediatric Infectious Diseases and the Spanish Society of Paediatric Chest Diseases have reviewed the available evidence. Consensus treatment guidelines are prop…

medicine.medical_specialtyPleural effusionNeumonía adquirida en la comunidadPopulationDrenaje pleuralPediatricsRJ1-570Empiema pleuralTherapeutic approachCommunity-acquired pneumoniaManagement of Technology and InnovationmedicineeducationIntensive care medicineNiñosVideotoracoscopiaeducation.field_of_studybusiness.industryPleural empyemaIncidence (epidemiology)medicine.diseaseEmpyemarespiratory tract diseasesPneumoniaFibrinolíticosbusinessAnales de Pediatría (English Edition)
researchProduct

Is kidney a new organ target in patients with obstructive sleep apnea? Research priorities in a rapidly evolving field.

2021

Abstract The bidirectional relationship between sleep disordered breathing and chronic kidney disease (CKD) has recently gained a lot of interest. Several lines of evidence suggest the high prevalence of coexistent obstructive sleep apnea (OSA) in patients with CKD and end-stage renal disease (ESRD). In addition, OSA seems to result in loss of kidney function in some patients, especially in those with cardio-metabolic comorbidities. Treatment of CKD/ESRD and OSA can alter the natural history of each other; still better phenotyping with selection of appropriate treatment approaches is urgently needed. The aim of this narrative review is to provide an update of recent studies on epidemiologic…

medicine.medical_specialtyPolysomnographyRenal functionDiseasePositive airway pressureSettore MED/10 - Malattie Dell'Apparato Respiratoriourologic and male genital diseasesKidneyEnd stage renal diseaseEnd-stage renal diseaseChronic kidney diseasePositive airway pressureEpidemiologymedicineHumansSleep-disordered breathingIntensive care medicineSleep Apnea Obstructivebusiness.industryResearchGeneral Medicinemedicine.diseaseObstructive sleep apneafemale genital diseases and pregnancy complicationsrespiratory tract diseasesNatural historyObstructive sleep apneaKidney Failure ChronicbusinessKidney diseaseSleep medicine
researchProduct

Perioperative management of obstructive sleep apnea: A systematic review

2018

Introduction Obstructive sleep apnea (OSA) is the leading sleep disordered breathing condition, with a prevalence rate of moderate to severe OSA of approximately 10-17% in the general population. Evidence acquisition We performed an Ovid-Medline search of all articles published up to August 2016. We included all articles providing updated evidence on epidemiology, pathophysiologic mechanisms and perioperative interventions. Evidence synthesis OSA is associated with a number of comorbidities and increased perioperative risks. Although in-laboratory polysomnography represents the gold-standard for diagnosis of OSA, it is costly and time-consuming. Anesthesiologists may screen patients for OSA…

medicine.medical_specialtyPolysomnographymedicine.medical_treatmentPopulation030209 endocrinology & metabolismPolysomnographyPerioperative CarePolysomnography.03 medical and health sciences0302 clinical medicine030202 anesthesiologyObstructive; Perioperative care; Polysomnography.; Sleep apnea; Sleep apnea syndromesmedicineIntubationContinuous positive airway pressureMED/41 - ANESTESIOLOGIAeducationSleep apnea syndromeseducation.field_of_studyPain PostoperativeSleep Apnea Obstructivemedicine.diagnostic_testContinuous Positive Airway Pressurebusiness.industryObstructiveSleep apneaSleep apneaApneaPerioperativemedicine.diseaserespiratory tract diseasesObstructive sleep apneaSleep apnea syndromeAnesthesiology and Pain MedicineEmergency medicinePostoperative Complicationmedicine.symptombusinessHuman
researchProduct